logo
Legislative committee focused on plotting Utah's nuclear path

Legislative committee focused on plotting Utah's nuclear path

Yahoo18-02-2025

The effort to form the Utah Energy Council, create energy development zones and create a nuclear energy consortium passed on a unanimous vote from the Senate Public Utilities, Energy and Technology Committee on Thursday.
HB249 by Rep. Carl Albrecht, R-Richfield, is a measure with a lot of moving parts with areas that will likely need to be tweaked in the years to come. Albrecht has insisted, however, it is a solid start to give Utah's energy portfolio a more diverse and solid future. It is a bill that to position the state to meet growing residential. industrial and commercial demand.
The Legislature this session is flush with energy bills, with leadership identifying energy as a top priority and one of the most pressing issues in Utah.
The bill by Albrecht does not mean advanced nuclear technology will pop up immediately in the state, but the consortium is tasked with making decisions based on science and what is most appropriate in Utah.
House Speaker Mike Schultz, R-Hooper, spoke favorably about the bill during a recent media availability.
'Nuclear is so much safer now. We are running into energy crisis in our nation. It's seen as most efficient and clean for our future,' he said. 'If we're not going to go to nuclear, what are we going to go to?'
He added: 'We have more requests for data centers in Utah than energy we use as a state. Whoever controls AI controls the world. We need more energy. We have an energy shortage. I'm glad the rest of the nation has come on board where Utah has been.'
Utah has been identified as a 'first mover' state — only one of a handful — by the Idaho National Laboratory's Frontier Project. That designation means Utah is positioned well to embrace nuclear, not only from a carbon free standpoint but as a way to stimulate economic development.
Utah was on the cusp of bringing a small modular reactor to life to serve independent power systems run by municipalities. Named the Carbon Free Power Project, the reactors would have been manufactured off-site and then trucked to the Idaho National Laboratory. The project pushed by the Utah Associated Municipal Power Systems went through a laborious permitting process through the U.S. Nuclear Regulatory Commission. It was the first small modular reactor in the country to receive a stamp of approval on its design.
But the delays and the escalating costs associated with the energy production eventually led to shelving the project, but UAMPS officials have said it is not totally off the table if costs come down. Congress is in the midst of tackling the permitting process and passed the ADVANCE Act to streamline the licensing process by the NRC.
At a conference last year in Park City, the dedication for the transformation to nuclear energy was clear among top political leaders in Utah.
The Rep. John Curtis, R-Utah, and state Senate President Stuart Adams, R-Layton, both said that the state has to aggressively pursue next generation nuclear technology if it is going to cut carbon emissions and meet energy demands.
'We want this to come to Utah,' Curtis, now Utah's junior senator, said at the time. 'We want to be a big part of this. We're ready for nuclear facilities here in our state, and we have communities who would welcome that. We have a lot of people in traditional energy sources that this would be very beneficial to them, and we're excited about that.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Graham offers Europe-friendly carveout to Russia sanctions bill
Graham offers Europe-friendly carveout to Russia sanctions bill

Yahoo

time44 minutes ago

  • Yahoo

Graham offers Europe-friendly carveout to Russia sanctions bill

Sen. Lindsey Graham plans to amend his crippling Russia sanctions bill to exempt countries that help Ukraine's defense against Russia, he told Semafor on Wednesday. After senators heard from countries worried about being caught up in 500% sanctions if they trade with Russia — a major energy producer in Europe — Graham said he plans to change the bill to omit levies on countries that have helped the fight against Russian President Vladimir Putin. 'Why don't we carve out for countries who are helping Ukraine? If you're providing military economic assistance to Ukraine, you get a carveout. So China, if you don't want to get sanctioned, help Ukraine … that makes sense to me,' Graham said in an interview. Graham said he spoke to President Donald Trump about his effort on Tuesday night. He declined to say what Trump thought of his latest proposal: 'I'll let him speak for himself.' White House press secretary Karoline Leavitt said this week the decision about sanctions is Trump's to make, signaling possible problems with the bill. Senate Majority Leader John Thune, R-S.D., indicated this week the Senate could move this month on a sanctions bill. Graham was more firm, predicting action on his plan in June 'unless there's some breakthrough.' 'I appreciate what President Trump has done. He's gone the extra mile … Putin's uninterested. He's gonna have another invasion soon. We've got a limited time to act,' Graham said. 'Let's put these sanctions out. Let's increase the cost to China and the other bad actors,' he added. 'It's the only way to keep this war from widening.' GOP leaders are closely consulting with the White House, even as many rank-and-file Republicans are tired of waiting for Trump's green light. Despite Leavitt's cool response, it's possible the Senate could cobble together a veto-proof majority for Graham's bill. A Ukrainian delegation is briefing senators today, per POLITICO.

RPD Q1 Earnings Call: Detection and Response Growth Offset by Exposure Management Pressures
RPD Q1 Earnings Call: Detection and Response Growth Offset by Exposure Management Pressures

Yahoo

time2 hours ago

  • Yahoo

RPD Q1 Earnings Call: Detection and Response Growth Offset by Exposure Management Pressures

Cybersecurity software maker Rapid7 (NASDAQ:RPD) fell short of the market's revenue expectations in Q1 CY2025 as sales rose 2.5% year on year to $210.3 million. Its non-GAAP EPS of $0.49 per share was 42.2% above analysts' consensus estimates. Is now the time to buy RPD? Find out in our full research report (it's free). Revenue: $210.3 million (2.5% year-on-year growth) Adjusted EPS: $0.49 vs analyst estimates of $0.34 (42.2% beat) Adjusted Operating Income: $32.35 million vs analyst estimates of $24.01 million (15.4% margin, 34.7% beat) Revenue Guidance for Q2 CY2025 is $212 million at the midpoint, below analyst estimates of $213.4 million Management raised its full-year Adjusted EPS guidance to $1.85 at the midpoint, a 3.4% increase Operating Margin: 0%, down from 4.7% in the same quarter last year Customers: 11,685, down from 11,727 in the previous quarter Annual Recurring Revenue: $837.2 million at quarter end, up 3.7% year on year Billings: $197.4 million at quarter end, up 7.3% year on year Market Capitalization: $1.54 billion Rapid7's first quarter results were shaped by continued momentum in its Detection and Response (D&R) business and ongoing challenges in its Risk and Exposure Management segment. CEO Corey Thomas highlighted that D&R now represents more than half of the company's annual recurring revenue, with mid-teens growth driven by customer demand for integrated threat detection and response solutions. Investments in automation and operational efficiency, including the new operations center in India, contributed to improved cost discipline. However, Thomas acknowledged that the Risk and Exposure Management business faced headwinds from a cautious spending environment, particularly among mid-market clients, and from delayed upgrade cycles in vulnerability management. The overall customer base remained stable, but the pace of upgrades and new deal closures in the risk segment lagged initial expectations, reflecting broader macroeconomic uncertainty. Looking forward, Rapid7's guidance reflects optimism in D&R's growth prospects but also caution due to variability in customer spending patterns. Management expects the D&R segment to remain the primary growth engine, supported by ongoing product innovation and expanded service offerings, especially for larger enterprise clients. However, Thomas warned that upgrades in the Risk and Exposure Management business could take longer to materialize, given current budget constraints in the mid-market segment. The company's revised outlook assumes continued resilience in D&R but incorporates a wider range of potential outcomes due to uncertain macroeconomic conditions. As Thomas stated, "We are seeing even though it may take a little bit longer, the D&R projects are closing. Now people want to make sure they get great value for what they're getting, but those D&R deals are closing and moving forward." Management attributed first quarter performance to strong demand in Detection and Response, while acknowledging delayed upgrades and spending caution in Risk and Exposure Management. Detection and Response drives growth: The company's Detection and Response platform, including Managed Detection and Response (MDR) and XDR capabilities, remained the largest and fastest-growing segment. Management cited persistent demand for integrated security solutions as organizations seek to manage complex and expanding threat landscapes more efficiently. Exposure Management upgrade cycle slow: The transition from standalone vulnerability management to the integrated Exposure Management platform progressed slower than anticipated. Management explained that many mid-market customers faced budget constraints, resulting in longer deal cycles and delayed upgrades. The company is refining packaging and pricing and working closely with partners to accelerate adoption. Operational efficiency initiatives: Rapid7 continued to invest in cost optimization, highlighting the ramp-up of its new operations center in India. This facility is intended to enhance service delivery at lower cost, particularly as international demand grows. CFO Tim Adams noted these efficiency measures helped deliver profitability above the guided range for the quarter. Macroeconomic headwinds: Management emphasized that budget scrutiny and delayed decision-making were particularly pronounced among mid-market and resource-constrained customers in sectors such as healthcare, education, and state and local government. In contrast, larger enterprise and regulated industries showed more stable demand. Product innovation and integration: The launch of the Intelligence Hub and enhancements to cloud security capabilities (CNAPP) were positioned as key differentiators. Management believes these investments will help drive future growth in both core D&R and Exposure Management businesses by offering unified risk insights and streamlined remediation workflows. Rapid7's updated outlook centers on ongoing D&R momentum, while recognizing that risk platform upgrades and macroeconomic pressures may limit near-term growth. D&R as primary growth engine: Management expects continued demand for Detection and Response services, especially among large enterprises seeking scalable managed security. The recently launched enterprise MDR (Managed Detection and Response) solution is anticipated to expand the company's reach into complex customer environments. Upgrade cycle in Exposure Management: The pace of migrating customers from legacy vulnerability management to the Exposure Management platform remains a central variable. Management noted that accelerating this transition could drive upside, but acknowledged that mid-market budget limitations and elongated sales cycles may continue to dampen progress in the near term. Operational discipline and international expansion: The company plans to prioritize investments in areas with higher growth potential, such as international markets and automation. The operations center in India is expected to contribute to both service delivery efficiency and improved margins, while investments in AI and automation are intended to support scalable, profitable growth even as market conditions remain uncertain. In the coming quarters, the StockStory team will be monitoring (1) the pace and scale of upgrades from vulnerability management to the integrated Exposure Management platform; (2) continued momentum and customer wins in Detection and Response, especially among larger enterprises; and (3) the impact of operational initiatives, including the India operations center, on cost structure and service delivery. Additionally, we will watch for evidence that new product launches and international expansion contribute meaningfully to growth. Rapid7 currently trades at a forward price-to-sales ratio of 1.8×. Should you double down or take your chips? Find out in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today. Sign in to access your portfolio

Cognixion and Pupil Lab partner to advance neural-visual research
Cognixion and Pupil Lab partner to advance neural-visual research

Yahoo

time2 hours ago

  • Yahoo

Cognixion and Pupil Lab partner to advance neural-visual research

Brain-computer interface (BCI) technology developer Cognixion, and eye-tracking platform specialist Pupil Lab, have forged a strategic partnership to unify their respective technology provisions in an effort to advance research capabilities centred on neurological disease. According to the companies, the partnership addresses a 'significant need' that exists in the research community for tools that can simultaneously track visual attention and neural activity. The combined technology will provide a higher level of data confidence, the companies said, and ultimately result in a platform that can adapt to patient needs wherein disease progression, such as in amyotrophic lateral sclerosis (ALS), may impact eye gaze ability. To meet this aim, Pupil Labs' eye-tracking software will be connected with Cognixion's Axon-R SDK, which was launched last year, to allow for seamless data collection and analysis across the platforms. Explicitly designed for research purposes, Cognixion's device uses visual stimuli, bio- and neurological feedback to measure and modulate brain activity. Cognixion CEO Andreas Forsland commented: "By combining Cognixion's neural interface expertise with Pupil Labs' industry-leading eye tracking technology, we're filling a critical role in sensor architecture that isn't available with any current BCI technologies. "This partnership enables a new generation of studies that can correlate visual attention with neural activity in real-time, potentially transforming our understanding of human cognition and interaction." BCI technologies are continuing to advance and receive considerable investor interest. Neuralink, the Elon Musk-owned developer of BCI chips that aim to restore movement in the limbs for individuals who may be paralysed or amputees, recently completed a $650m Series E fund raise. However, as BCI technologies continue to develop, some observers hold concerns around the potential risks posed by the neural data these devices will generate. US Democratic party leader Chuck Schumer wants to get ahead of the curve and shore up privacy protections while the technology largely remains at the developmental stage. In a recent letter to FTC chair Andrew Ferguson, Schumer pointed out the following: 'Unlike other personal data, neural data … can reveal mental health conditions, emotional states, and cognitive patterns, even when anonymised. This information is not only deeply personal; it is also strategically sensitive.' "Cognixion and Pupil Lab partner to advance neural-visual research" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store